A new standard in
cervical cancer screening
Teal’s at-home collection kit, unparalleled accuracy, and end-to-end digital platform delivers high kit return rates, results a provider can trust, and delighted patients.
Accurate. Effective. Preferred. Ready to scale.
Leading Accuracy
The most accurate at-home option. Teal has equal CIN2+ detection to clinical collection.
Drives Adherence
Thoughtful design that meets women where they are and delivers best-in-class return rates.
Loved by Women
98 NPS and 99% CSAT. Women enjoy the comfort and convenience of screening with Teal.
Easy to Implement
Enables partners to offer the new standard of care with minimal administrative overhead, increasing your clinical capacity.
For Providers & Health Systems
Your providers place the order. Teal sends the kit, drives adherence, and navigates patients with an abnormal result back into your care. You receive all results.
The new standard of care
Self-collect primary HPV is the recommended way to screen average-risk women 25–65.
Results you can trust
The only at-home option that brings screening home without degrading accuracy — matching the in-office exam.
Reach without added workload
Close screening gaps across your panel without new clinical capacity or admin overhead.
Patients stay yours
Be informed of anyone with an abnormal result so you can coordinate care with the patient.
94%
of patients in the SELF-CERV trial preferred at-home over in-clinic screening.
For Health Plans & Employers
Teal handles the experience end-to-end. This includes a Teal Medical provider evaluating clinical eligibility and placing the order, then sharing back data as appropriate.
A benefit women actually use
Coverage was never the barrier, the exam is. Teal turns a covered service into completed screenings.
Reaches every woman
Effective at engaging both those who avoid screening and those already compliant.
Prevention that pays off
Improve HEDIS scores and Quality Measures. 1 in 4 women are overdue, and risk climbs each year. Early detection means >90% survival vs. <20% caught late.
Goodwill that reflects on you
98 NPS and 99% CSAT — members associate the experience with your plan.
1 in 4
women in the US is currently not up-to-date on cervical cancer screening
The recommended test for average risk women 25-65 years old
Teal Health performs primary HPV testing — the recommended screening method by the American Cancer Society, ACOG, and HRSA — and accepted by HEDIS for cervical cancer screening adherence.
Teal delivers results providers and patients trust, alongside the dedicated platform and provider network needed to safely bring care into the home.
Backed by published research and the leading experts in women's health
JAMA
Network
Open
Fitzpatrick MB, Behrens CM, Hibler K, et al. JAMA Network Open. 2025;8(5):e2511081. doi:10.1001/jamanetworkopen.2025.11081
1.00
Relative sensitivity for detecting CIN2+ cervical dysplasia vs. clinician-collected samples.
Research shows self-collect leads to higher follow-up care and engagement in screening.1
Let’s build a partnership that fits
Tell us about your organization and the population you serve. Our partnerships team will reach out to discuss opportunities.